 Cortexyme, Inc. Nasdaq: CRTX, a clinical stage biopharmaceutical company pioneering potential therapeutics for Alzheimers and other degenerative diseases, today announced Stephen Dominy, M.D., the companys chief scientific officer and co-founder, will participate in a fireside chat hosted by LifeSci Capital on Thursday, July 30 at 3:00 p.m. EDT 12:00 p.m. PDT. The conversation will focus on the link between P. gingivalis and Alzheimers disease pathology. 